Research background · Updated November 1, 2026
AOD-9604 Research: Publications, Study Types and Background
Short answer
AOD-9604. As of November 1, 2026, PubMed indexes 22 records matching AOD-9604, the earliest from 2000; 0 were published in 2021–2025 and 9 are reviews. ClinicalTrials.gov lists 0 registered studies matching the compound.
- PubMed records
- 22
- Earliest record
- 2000
- Published 2021–2025
- 0
- Reviews
- 9
- Animal-only studies
- 3
- Registered studies
- 0
Publications per year, 2006–2025
1 records in 2016–2025 against 12 in 2006–2015; the busiest year was 2014, with 4.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 0 |
| 2009 | 0 |
| 2010 | 0 |
| 2011 | 0 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 0 |
| 2018 | 0 |
| 2019 | 0 |
| 2020 | 0 |
| 2021 | 0 |
| 2022 | 0 |
| 2023 | 0 |
| 2024 | 0 |
| 2025 | 0 |
Study types
| All PubMed records | 22 |
|---|---|
| Reviews | 941% |
| Animal studies (no human subjects indexed) | 314% |
| Indexed as clinical trials | 00% |
| Registered on ClinicalTrials.gov | 0 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 1 of the most-cited and most recent AOD-9604 papers report, in their own authors’ terms. Each line links the paper it came from.
Development history
This review reports that AOD-9604 was in development for the potential treatment of obesity, with phase IIa trials underway by February 2002.
ReviewWilding J 2004Current opinion in investigational drugsPMID 15134286
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 22 of the 22 records. They describe what the literature is about, not what AOD-9604 does.
- Somatostatin6 papers
- Obesity6 papers
- Anti-Obesity Agents5 papers
- Human Growth Hormone5 papers
- Performance-Enhancing Substances3 papers
- Substance Abuse Detection3 papers
- Doping in Sports3 papers
- Clinical Trials as Topic3 papers
Key papers
Earliest indexed record
Ng FM (2000). Hormone research.
PMID 11146367Most-cited paper · 62 citations
Halford JC (2006). Current opinion in investigational drugs (London, England : 2000).
PMID 16625817Most-cited #2 · 51 citations
Thevis M (2014). Journal of pharmaceutical and biomedical analysis.
PMID 24906629Most-cited #3 · 38 citations
Thomas A (2016). Journal of separation science.
PMID 26578461
Citation counts from NIH iCite, among the 22 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| CAS | 221231-10-3 |
|---|---|
| Molecular formula | C78H123N23O23S2 |
| Molecular weight | 1815.1 g/mol |
| Synonyms | AOD 9604, AOD9604, AOD-9604, RefChem:113278, Tyr-somatostatin (177-191) |
Identity data from PubChem, retrieved November 1, 2026, on the AOD-9604 page.
How these numbers were counted
- PubMed search, run November 1, 2026:
AOD9604[tiab] OR "AOD-9604"[tiab]re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
AOD9604re-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use AOD-9604 outside a laboratory.
Wholesale supply
AOD-9604, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
AOD-9604 research questions
How much research has been published on AOD-9604?
PubMed indexes 22 records matching AOD-9604 (searched November 1, 2026), including 9 reviews and 0 records indexed as clinical trials. 0 were published in the five years 2021–2025.
When was AOD-9604 first described in the literature?
The earliest PubMed record matching AOD-9604 is from 2000 (Ng FM, Hormone research, PMID 11146367).
What topics does the AOD-9604 literature cover?
The subject headings PubMed indexers most often marked as a main topic of AOD-9604 papers are Somatostatin, Obesity, Anti-Obesity Agents, Human Growth Hormone. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is AOD-9604 sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy AOD-9604 wholesale for research?
We source AOD-9604 to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.